Protocol Ledger

NCT07872423 · Phase III · RECRUITING

Phase III Trial of VDJ001 In Patients With Idiopathic Multicentric Castleman Disease

Interventional Phase III clinical trial protocol NCT07872423 sponsored by Beijing VDJBio Co in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-01-27 Enrollment: 45 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07872423
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)45 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07872423
Protocol FieldVerified Registry Value
NCT IdentifierNCT07872423
Consolidated Lead SponsorBeijing VDJBio Co
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment45 participants (ESTIMATED)
Registered Start Date2025-01-27
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI